Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer
Camilla Pecoraro, Beatrice Faggion, Beatrice Balboni, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100779-100779
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 515
Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 231
Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
Motahareh Mortazavi, Fatemeh Moosavi, Miriam Martini, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103749-103749
Closed Access | Times Cited: 75
Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents
Enrique Domínguez‐Álvarez, Bálint Rácz, Małgorzata Anna Marć, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100844-100844
Open Access | Times Cited: 63
Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma
Manfei Pi, Huixian Kuang, Chunyan Yue, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100822-100822
Closed Access | Times Cited: 53
Salt-Tolerant Plants, Halophytes, as Renewable Natural Resources for Cancer Prevention and Treatment: Roles of Phenolics and Flavonoids in Immunomodulation and Suppression of Oxidative Stress towards Cancer Management
Hamdoon A. Mohammed, Abdul‐Hamid Emwas, Riaz A. Khan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5171-5171
Open Access | Times Cited: 35
Advances and Prospects in the Treatment of Pancreatic Cancer
Huaiyu Duan, li li, Shiming He
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3973-3988
Open Access | Times Cited: 27
DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma
Yangfan Liu, Yu Sun, Jin Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
The role of acetylation and deacetylation in cancer metabolism
Cuicui Wang, Xiaoxin Ma
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications
Ashok Kumar Nayak, Hannah Streiff, Iván González, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 178-178
Open Access
Novel dual-targeting PROTAC degraders of GSK-3β and CDK5: A promising approach for pancreatic cancer treatment
Neerasa Jayaprakash, Byeonggwan Kim, Hye Jin Chung
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118085-118085
Closed Access
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 30
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β
Shuo Wang, Peng Du, Yudong Cao, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 24
The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/β-catenin pathway
Yuwei Zhang, Haili Zhou, Caifei Ding
Gynecological Endocrinology (2023) Vol. 39, Iss. 1
Open Access | Times Cited: 13
Lysine-Specific Demethylase 1 Promises to Be a Novel Target in Cancer Drug Resistance: Therapeutic Implications
Feifei Yang, Xue-Li Xu, Ting Hu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4275-4293
Closed Access | Times Cited: 11
Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects
Zimeng Cheng, Tianyue Han, Jingtong Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116065-116065
Closed Access | Times Cited: 11
Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
Inês Mendes, Nuno Vale
Biomedicines (2024) Vol. 12, Iss. 1, pp. 227-227
Open Access | Times Cited: 3
An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line
John M. Baust, Kimberly L. Santucci, Robert G. Van Buskirk, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 450-450
Open Access | Times Cited: 16
COL11A1-Driven Epithelial–Mesenchymal Transition and Stemness of Pancreatic Cancer Cells Induce Cell Migration and Invasion by Modulating the AKT/GSK-3β/Snail Pathway
Hui Wang, Huichao Zhou, Ní Hóng, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 391-391
Open Access | Times Cited: 15
New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis
Shenjin Lai, Peng Wang, Jingru Gong, et al.
PeerJ (2023) Vol. 11, pp. e16635-e16635
Open Access | Times Cited: 9
Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer
Dengchuan Wang, Yonggang Zhang, Xiaokang Wang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
Small Extracellular Vesicles Derived from Helicobacter Pylori‐Infected Gastric Cancer Cells Induce Lymphangiogenesis and Lymphatic Remodeling via Transfer of miR‐1246
Lu Chen, Li Xie, Shengkui Qiu, et al.
Small (2023) Vol. 20, Iss. 13
Closed Access | Times Cited: 8
Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β
Long-Jiang Chen, Lun Wu, Wei Wang, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 4
Open Access | Times Cited: 14
GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer
Shilong Han, Chuanwu Cao, Rui Liu, et al.
Cellular Oncology (2022) Vol. 45, Iss. 3, pp. 429-446
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top